The Group's principal activity is to discover, develop and market innovative therapies for immune-inflammatory-related diseases through the regulation of cells, genes and proteins associated with diseases. It operates in one segments: Human Pharmaceuticals and Stem Cell Therapies. The Human Pharmaceuticals segment includes Signal Pharmaceuticals, LLC, a privately held San Diego-based biopharmaceutical company focused on the discovery and development of drugs that regulate genes and proteins associated with diseases. The Stem Cell Therapies segment develops the technology for the recovery of stem cells from human placental tissues following the completion of full-term, successful pregnancies.
Alacra Alerts:
Receive alerts on the latest reports on Celgene Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
